News & Events
The latest developments in medical and technological advances in health and SCHILLER’s participation in various events.
Interstitial lung diseases (ILDs) encompass many unrelated conditions with both known and unknown etiologies, which often present diagnostic and therapeutic
The 6-minute walk test (6MWT) is used to objectively assess the exercise capacity of patients with moderate to severe pulmonary
SCHILLER electrocardiographs are sophisticated pieces of Swiss technology. Our founder, Alfred Schiller, pioneered developments for ECGs, such as keyboards, integrated
Vaping as the Cause of EVALI (E-cigarette or Vaping Product Use–Associated Lung Injury), a pulmonary disease that can be severe
Oscillometry is a non-invasive method for measuring the mechanical properties of the respiratory system, which can enhance our understanding and
Vital signs monitors are tools that can make a significant difference in postoperative patient outcomes. About half of adverse events
Doral, Florida – 5/28/2024 – SCHILLER Americas has been awarded a national group purchasing agreement and Technology Breakthrough Designation
Resistant or refractory arterial hypertension is defined as blood pressure that remains above the target despite the use of three
By América Torres peoplecreations/Freepik With the aim of providing you with information that may be useful in your medical practice,
